A clinical trial involving oxytocin was listed as withdrawn as of November 6, 2026. The study, titled "Reducing Self-Dehumanization to Examine Oxytocin and Suicide Risk," is registered under identifier NCT06713473. Its phase is listed as not applicable. The trial's current status on record is withdrawn. No results or outcome data are included in this update. The registration does not state a reason for the withdrawal. No information on enrollment, trial design, or further study plans is provided in this record. This update reflects only the status change noted in the trial registry as of the listed date. Readers can consult the official clinical trial registry page for additional details on the study record. For general background on this compound, see the compound overview.
Oxytocin Trial NCT06713473 on Self-Dehumanization, Suicide Risk Withdrawn
See the full oxytocin overview
Source: https://clinicaltrials.gov/study/NCT06713473